Geoffrey Kline, DO, PhD

Projects

Projects per year 2013 2015 2017 2024

• 1 Active
• 6 Finished

Projects per year

Search results

• Finished

  A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF).

  Kline, G.

  Boehringer Ingelheim International GmbH

  25/04/17 → 24/04/21

  Project: Research

• A phase III randomised, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10 mg compared to placebo, in patients with chronic Heart Failure with reduced Ejection Fraction (HFrEF).

  Kline, G.

  Boehringer Ingelheim International GmbH

  25/04/17 → 24/04/21

  Project: Research

• PROMINENT- PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETES

  Kline, G.

  Kowa Research Institute, Inc.

  31/03/17 → 31/03/21

  Project: Research

• A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Effects of Bempedoic Acid (ETC-I 002) on the Occurrence of Major Cardiovascular Events in Patients with, or at High Risk For,Cardiovascular Disease Who Are Statin Intolerant

  Kline, G.

  Esperion Therapeutics, Inc.

  13/02/17 → 13/02/21

  Project: Research

• A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Long-term Safety and Tolerability of PF-04950615 in Subjects with Primary Hyperlipidemia or Mixed Dyslipdemia at Risk of Cardiovascular Events

  Kline, G.

  Pfizer, Inc.

  17/03/15 → 31/03/20

  Project: Research

• A Readomized. Double-blind, Placebo-controlled,Parallel-group Studfy to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patgients Who Have Recently Experienced an Acute Coronary Syndrome

  Kline, G.

  Sanofi Pasteur, Inc.

  31/01/13 → 30/01/20

  Project: Research